Chang David D

Chang David D is listed in filings as President and CEO at Allogene Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 18, 2026, including sale activity. Recent filings connect the profile to Allogene Therapeutics, Inc. (ALLO). The current snapshot covers public activity from Jan 28, 2025 to Mar 18, 2026. Reported amounts are shown as $118.0K to $171.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.